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INTRODUCTION
Cystic fibrosis (CF; Mckusick 219700) is a lethal disease,
which is induced by mutations in the cystic fibrosis trans-
membrane conductance regulator (CFTR) gene on chromo-
some 7q31 (1). Although CF is one of the most frequent
autosomal-recessive disorders in Western countries (1/2,000-
1/3,000) (2), it is extremely rare in the Asians (1 in 350,000
in Japanese population) and only a few cases of CF were con-
firmed by mutation analysis in Korea (3-5). 
The clinical features of CF are variable and depend on age
at diagnosis, supportive care and treatment. The diagnosis
of CF is suspected by the presence of typical clinical features
such as meconium ileus at birth, recurrent or persistent pneu-
monia, malabsorption causing failure to thrive and growth
problems, salt-wasting syndromes or obstructive azoospermia
(6). The demonstration of a high sweat chloride on repeated
measurements or by identifying CF mutations in two alleles
could confirm the diagnosis of CF. Since CF is an extremely
rare disease in Asians, sweat chloride test and neonatal screen-
ing test has not been available in Korea and there is a risk of
underdiagnosis or delayed diagnosis of CF even in suspected
cases. 
Recently, we experienced a Korean infant with CF, who
was diagnosed by genetic analysis of the CFTR gene. We
present this case with a brief review of the literatures.
CASE REPORT
A 4-month of age boy was brought to emergency room at
Asan Medical Center because of respiratory difficulty. In his
past medical history, he was born with birth weight of 3.4
kg at the 39st week of gestation and he was the first child
born to non-consanguineous parents. Delay of meconium
passage and abdominal distension developed just after birth.
He was diagnosed as meconium ileus and ileal resection was
performed at his 5th day. Until 4-month old, he had admit-
ted twice because of respiratory difficulty and treated as acute
bronchiolitis. He was fed breast milk and gained body weight
slowly up to 5.2 kg (3-10th percentile). 
At 4-month of age, the respiratory symptoms such as
cough, wheezing and respiratory difficulty recurred, and he
was referred to Asan Medical Center. His respiratory rate
was 56 breaths per minute and he exhibited 87% oxygen
saturation in room air. Upon the findings of physical exami-
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Identification of a Novel Mutation of CFTR Gene in a Korean Patient
with Cystic Fibrosis
Cystic fibrosis (CF) is the most common lethal autosomal recessive disease in Cau-
casians, but rare in Asians. The mutations of cystic fibrosis transmembrane con-
ductance regulator (CFTR) gene are responsible for CF. To date, less than 5 cases
of CF have been reported and a few of them diagnosed based on the genotype of
the CFTR gene in Korea. We encountered a 4-month-old Korean infant with CF
and the diagnosis was confirmed by CFTR gene mutation analysis. The patient
underwent surgical operation, due to meconium ileus at birth. He suffered by recur-
rent respiratory infections, failure to thrive, fatty liver with hepatomegaly, and cholesta-
sis. The mutations of the CFTR gene were identified in the patient and his parents.
The patient was a compound heterozygote with a nonsense mutation of c.263T>G,
resulting in an amino acid change of p.Leu88X in exon 3. It was previously described
in a Korean patient with CF. The other is a novel mutation; c.2089-2090insA muta-
tion (p.Arg697LysfsX33) in exon 13. The mutation c.263T>G was inherited from
his father, and the c.2089-2090insA mutation from his mother. Respiratory infec-
tion was recovered by supportive care, and cholestasis was improved slowly with
sufficient feeding and supplementation of pancreatic exocrine enzymes. He is 19-
month old now and shows catch-up growth. We report a novel CFTR mutation in a
Korean infant with CF.
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nation, diffuse crackles and wheezing were heard throughout
entire lung field and the liver was palpated as 4 cm widths
below the right subcostal margin. There was no evidence of
exocrine pancreatic insufficiency and malabsorption yet. Hy-
poalbuminemia (2.5 g/dL), elevated liver enzyme (AST/ALT:
59/42 IU/L) and mild jaundice (total bilirubin/direct biliru-
bin: 4.3/2.5 mg/dL) were detected.
Chest radiographs, computed tomography scan of the chest
revealed multifocal atelectases and peribronchial infiltration
(Fig. 1). No respiratory tract anomaly was found by bron-
Fig. 1. Chest plain radiograph (A) and computed tomographic image (B) shows multifocal atelectases, peribronchial pneumonic infiltra-
tion and air-trapping of underlying lung parenchyme.
A B
Primer sequence (5′ →3′ )
Exon Forward Reverse
3 TACTTGGGTAATCTCCTTGG GGATTGGATTCATCCTTTAT
13 AACTGAGACCTTACACCGTTT GTGACACTTTTCGTGTGGAT
Table 1. Primer pairs used to amplify the CFTR coding sequence
C.263T>G
p.Leu88X
C.2089_2090insA
p.Arg697LysfsX33
C.[263T>G]+[2089-2090insA]
p.[Leu88X]+[Arg697LysfsX33]
Fig. 2. Partial genomic DNA sequences of CFTR gene for the pati-
ent and his parents were showed. The patient had compound
heterozygote mutations including a nonsense and a frameshift
mutation and his father and mother carried each of these muta-
tions respectively.
Fig. 3. Growth chart demonstrates improvement in height and
weight status with supplementation of pancreatic exocrine enzymes
and multi-vitamins.
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choscopic examination. Moderate fatty liver and mild hep-
atomegaly was detected by abdominal ultrasonography. Oxy-
gen supplementation via nasal prong (2-5 L/min) and sup-
portive care including bronchodilator therapy were started.
But his breathing became more difficult at 8th hospital day,
and he was placed on artificial ventilation therapy for 28 days.
Staphylococcus aureus and Stenotrophomonas maltophilia were cul-
tured from his bronchial secretion. Tests for TORCH infec-
tion, causing neonatal cholestasis and lung infiltration, were
all negative. 
From his past medical history and clinical course, CF was
suspected. The sweat chloride test could not be performed
due to his poor medical condition. To confirm the diagnosis
of cystic fibrosis, direct sequencing analysis of all coding exons
and the exon-intron boundaries of CFTR gene was performed.
Used primer sequences are listed in Table 1. He was a com-
pound heterozygote of two mutations: c.263T>G (p.Leu88X)
in exon 3 from his father and c.2089_2090insA (p.Arg697-
LysfsX33) in exon 13 from his mother (Fig. 2). Both of them
belong to the mutation class I, which is most severe group
of CFTR mutations (7). The c.263T>G (p.Leu88X) has been
reported in a Korean CF patient already (8), and the c.2089_
2090insA (p.Arg697LysfsX33) was a novel frameshift muta-
tion.
He recovered by artificial ventilation, mucolytics, antibi-
otics and active physiotherapy. Hypoalbuminemia, cholesta-
sis and hepatomegaly were improved slowly with sufficient
feeding, supplementation of pancreatic exocrine enzymes,
multi-vitamins and essential fatty acid. He is 19-month old
now and has admitted to the hospital at the age of 12 months
because of hyponatremic dehydration with metabolic alka-
losis following to acute gastroenteritis. However, he shows
catch-up growth and his height and weight is with in 10-
25th percentiles with supplementation of pancreatic exocrine
enzymes and multi-vitamins (Fig. 3).
DISCUSSION
The causing gene of CF is the CFTR gene, which is locat-
ed on chromosome 7q31. The gene spans 250 kilobases,
encoding 1,480 amino acids in the mature protein. CFTR
protein has been shown to function as a regulated chloride
channel, which in turn may regulate the activity of other
chloride and sodium channels at the cell surface (1, 9). More
than 1,200 disease-associated mutations have been described
already, and the most common mutation in Western popu-
lation is  F508, which is accounting for approximately 70%
of defective CFTR alleles (9). Over 90% of CFTR gene muta-
tions could be identified by using a panel of 70 mutations
in general population of the United States (10). In Korean
population, However, only 13 mutations have been report-
ed by now (3, 5, 8, 11), and these are not frequently found
mutations in Caucasians. Our patient is a compound het-
erozygote with a known mutation of Leu88X and a novel
mutation of Arg697LysfsX33. This novel mutation is locat-
ed in exon 13, which belongs to highly charged regulatory
domain. Some mutations such as Glu692X and Glu695Glyf-
sX35 were already reported, and these are located near Arg-
697LysfsX33 mutation. The all patients who carried these
mutations showed severe clinical phenotypes (12, 13). Both
two mutations of our patient are classified as mutation Class
I, which is most severe group of CFTR mutations leading
to premature termination of mRNA and virtually absence
of functional CFTR protein (14). Clinical consequences of
the CFTR defect for various organs affected in CF patients
are site-specific and range from severe to mild. Although
the correlation between genotype and phenotype is not fully
understood in CF, genotype is thought to be a good predic-
tor of exocrine pancreatic function (pancreatic insufficiency
vs. pancreatic sufficiency) (15). However, respiratory symp-
toms are poorly correlated to CFTR genotype with few excep-
tions (16). Meconium ileus is not genotype-dependent in the
fashion characteristic for pancreatic function, but this symp-
tom is almost exclusively observed in patients with pancre-
atic insufficiency and severe CFTR genotypes (17). Early and
severe presentation of our patient might be caused by severe
mutations and the absence of CFTR function.
In conclusion, we experienced one case of CF with a novel
mutation of CFTR gene. Although CF is a rare disease in
Korea, it should be considered in the differential diagnosis
of any infant or child presenting with early onset recurrent
bronchiolitis, especially in patients with past history of meco-
nium ileus.
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